03/12/2015 - 11:50am

Drug Channels Institute on Thursday listed the leading specialty pharmacy players. 

03/11/2015 - 1:33pm

A new MIT study published Wednesday suggests that a more powerful H1N1 influenza strain may be making its way through India. 

03/11/2015 - 12:50pm

Mylan expanded its portfolio of generic products with the U.S. launch of buprenorphine hydrochloride sublingual tablets in 2-mg and 8-mg strengths, the generic version of Subutex from Reckitt Benckiser.

03/11/2015 - 12:40pm

Mylan on Wednesday announced the launch of disulfiram tablets USP in dosage strengths of 250 mg and 500 mg.

03/11/2015 - 12:27pm

Mylan launched its fentanyl transdermal system in 37.5-, 62.5- and 87.50-mcg/hr dosage strengths in the United States.

03/10/2015 - 3:52pm

Teva Pharmaceuticals will sell its Sellersville, Penn., facility to G&W Labs. According to Teva, the move supports its mission of streamlining operations by reducing excess manufacturing capacity.

03/10/2015 - 3:38pm

ANI Pharmaceuticals acquired the approved abbreviated new drug application for flecainide acetate tablets USP in 50-mg, 100-mg and 150-mg dosage strengths.

03/10/2015 - 2:46pm

The Food and Drug Administration recently published bio-equivalence guidance documents. 

03/10/2015 - 1:50pm

HDMA’s 2015 Distribution Management Award goes to Cardinal Health for streamlined receiving and replenishing solutions.